A detailed history of Robinson Smith Wealth Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Robinson Smith Wealth Advisors LLC holds 580 shares of REGN stock, worth $431,810. This represents 0.52% of its overall portfolio holdings.

Number of Shares
580
Previous 802 27.68%
Holding current value
$431,810
Previous $843 Million 27.67%
% of portfolio
0.52%
Previous 0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1024.09 - $1201.76 $227,347 - $266,790
-222 Reduced 27.68%
580 $610 Million
Q1 2024

Apr 25, 2024

BUY
$902.69 - $993.35 $902 - $993
1 Added 0.12%
802 $772 Million
Q4 2023

Feb 12, 2024

BUY
$775.18 - $881.7 $620,919 - $706,241
801 New
801 $704 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Robinson Smith Wealth Advisors LLC Portfolio

Follow Robinson Smith Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robinson Smith Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robinson Smith Wealth Advisors LLC with notifications on news.